Position in KURA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$767,483
+$295,179 QoQ
Shares Held
69,962
+20.4% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 220 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. KURA ranks #183 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in KURA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $767,483 | 69,962 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $472,304 | 58,094 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $475,103 | 45,727 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $371,337 | 41,959 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $228,336 | 39,573 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $209,338 | 31,718 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $244,489 | 28,070 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $463,606 | 23,726 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $474,681 | 23,054 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $429,756 | 20,148 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $247,451 | 17,208 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $317,987 | 34,867 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $257,813 | 24,368 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $290,584 | 23,760 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $282,761 | 22,785 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $365,377 | 26,748 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $692,800 | 37,796 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $600,957 | 37,373 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $309,078 | 22,077 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $737,119 | 39,355 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $688,446 | 33,019 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $897,459 | 31,746 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $778,026 | 23,822 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $640,253 | 20,896 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||